Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Transfusion Medicine and Hemotherapy

• Publication date

  2007-12-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000111755PMID 21547105PMCID PMC3083275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measuring Therapeutic Response In Chronic Graft-Versus-Host Disease.

  2009cited by this paper
• Chronic graft-versus-host disease.

  2008cited by this paper
• Haemopoietic stem cell transplantation—an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology

  2007cited by this paper
• Extracorporeal Photopheresis as a Treatment for Patients with Severe, Refractory Atopic Dermatitis

  2007cited by this paper
• A new device to study ex-vivo the effects of extracorporeal photochemotherapy on the immune system.

  2007cited by this paper
• Avoiding calcineurin inhibitors in the early post‐operative course in high‐risk liver transplant recipients: The role of extracorporeal photopheresis

  2007cited by this paper
• Regulating regulatory T cells

  2007cited by this paper
• Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62L+ Functional Regulatory T-Cells in Patients With Graft-Versus-Host Disease

  2007cited by this paper
• Extracorporeal Photochemotherapy for the Treatment of Chronic Graft‐Versus‐Host Disease: Trend for a Possible Cell Dose‐Related Effect?

  2007cited by this paper
• Clinical‐scale generation of strongly CD83‐expressing dendritic cells using extracorporeal photopheresis

  2007cited by this paper
• Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?

  2006cited by this paper
• A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.

  2006cited by this paper
• Extracorporeal photopheresis: a focus on apoptosis and cytokines.

  2006cited by this paper
• Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

  2006cited by this paper
• Modulation of graft-versus-host disease: role of regulatory T lymphocytes.

  2006cited by this paper
• Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials

  2006cited by this paper
• Transimmunization for cutaneous T cell lymphoma: A phase I study

  2006cited by this paper
• Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis

  2006cited by this paper
• Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

  2006cited by this paper
• The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.

  2006cited by this paper
• Update on extracorporeal photochemotherapy for graft-versus-host disease treatment

  2005cited by this paper
• New approaches for preventing and treating chronic graft-versus-host disease.

  2005cited by this paper
• International forum: Italy

  2005cited by this paper
• Lymphocytes treated by extracorporeal photopheresis can down‐regulate cytokine production in untreated monocytes

  2005cited by this paper
• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

  2005cited by this paper
• Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.

  2005cited by this paper
• Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses.

  2005cited by this paper
• The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo.

  2005cited by this paper
• Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors

  2005cited by this paper
• Chronic graft versus host disease

  2004cited by this paper
• Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies

  2004cited by this paper
• The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.

  2004cited by this paper
• Extracorporeal photochemotherapy for graft versus host disease in pediatric patients.

  2003cited by this paper
• Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.

  2003cited by this paper
• Extracorporeal Photopheresis in Lung Transplantation

  2003cited by this paper
• Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.

  2003cited by this paper
• Mechanisms of action of extracorporeal photochemotherapy.

  2003cited by this paper
• Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

  2003cited by this paper
• Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma.

  2003cited by this paper
• Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation

  2003cited by this paper
• Extracorporeal photopheresis technical aspects.

  2003cited by this paper
• Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.

  2002cited by this paper
• Mononuclear cell collection in patients undergoing extra‐corporeal photo‐chemotherapy for acute and chronic graft‐vs.‐host‐disease (GvHD): Comparison between COBE Spectra version 4.7 and 6.0 (AutoPBSC)

  2002cited by this paper
• Transimmunization: the science catches up to the clinical success.

  2002cited by this paper
• Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study

  2002cited by this paper
• Transimmunization and the evolution of extracorporeal photochemotherapy.

  2002cited by this paper
• Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat

  2002cited by this paper
• Extracorporeal photopheresis in cutaneous T‐cell lymphoma 
and graft‐versus‐host disease induces both immediate 
and progressive apoptotic processes

  2002cited by this paper
• Transimmunization, a novel approach for tumor immunotherapy.

  2002cited by this paper
• Extracorporeal photopheresis in chronic graft-versus-host disease

  2002cited by this paper
• Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection.

  2002cited by this paper
• Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.

  2002cited by this paper
• Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.

  2002cited by this paper
• Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease.

  2001cited by this paper
• Extracorporeal photochemotherapy for treatmentof acute and chronic GVHD in childhood

  2001cited by this paper
• Extracorporeal photochemotherapy in patients with steroid‐dependent Crohn’s disease: a prospective pilot study

  2001cited by this paper
• Induction of human tumor‐loaded dendritic cells

  2001cited by this paper
• Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response.

  2001cited by this paper
• Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats

  2001cited by this paper
• Extracorporeal photopheresis for the treatment of lung allograft rejection.

  2000cited by this paper
• Subclinical rejection--a potential surrogate marker for chronic rejection--may be diagnosed by protocol biopsy or urine spectroscopy.

  2000cited by this paper
• Photopheresis in Cutaneous T-Cell Lymphoma: Five-Year Experience

  2000cited by this paper
• Photochemotherapy for GvHD

  2000cited by this paper
• Effectiveness of extracorporeal photochemotherapy in treating refractory chronic graft-versus-host disease.

  2000cited by this paper
• Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis.

  2000cited by this paper
• Short-Time Extracorporeal Photochemotherapy in the Treatment of Drug-Resistant Autoimmune Bullous Diseases

  1999cited by this paper
• Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis.

  1999cited by this paper
• Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T‐cell lymphoma and graft‐versus‐host disease patients

  1999cited by this paper
• A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis

  1999cited by this paper
• Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.

  1999cited by this paper
• Extracorporeal Photopheresis of Cutaneous T-Cell Lymphoma Is Associated with Reduction of Peripheral CD4+ T Lymphocytes

  1998cited by this paper
• Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease.

  1998cited by this paper
• Successful treatment of recurrent rejection in renal transplant patients with photopheresis.

  1998cited by this paper
• Extracorporeal photochemotherapy for chronic erosive lichen planus.

  1998cited by this paper
• Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

  1998cited by this paper
• Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy

  1997cited by this paper
• Photopheresis—A possible treatment of multiple sclerosis? Report of two cases

  1997cited by this paper
• Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T‐cell lymphoma

  1997cited by this paper
• Treatment of cutaneous T‐cell lymphoma with extracorporeal photochemotherapy

  1996cited by this paper
• Treatment of graft versus host disease (GVHD) by photopheresis?

  1996cited by this paper
• Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.

  1996cited by this paper
• Photopheresis for the treatment of cutaneous T-cell lymphoma.

  1995cited by this paper
• Renal allograft rejection controlled by photopheresis.

  1995cited by this paper
• Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease.

  1995cited by this paper
• Photopheresis for chronic rejection of lung allografts.

  1995cited by this paper
• Psoriatic arthritis: one year of treatment with extracorporeal photochemotherapy.

  1994cited by this paper
• Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders.

  1994cited by this paper
• Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.

  1994cited by this paper
• Animal models

  1994cited by this paper
• Photopheresis in systemic sclerosis: clinical and serological studies using markers of collagen metabolism.

  1993cited by this paper
• Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis.

  1993cited by this paper
• [Treatment of refractory rheumatoid polyarthritis by extracorporeal photochemotherapy].

  1993cited by this paper
• Successful treatment of heart transplant rejection with photopheresis.

  1992cited by this paper
• Photopheresis Versus Corticosteroids in the Therapy of Heart Transplant Rejection: Preliminary Clinical Report

  1992cited by this paper
• Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.

  1992cited by this paper
• Extracorporeal photochemotherapy in the treatment of severe psoriatic arthropathy

  1992cited by this paper
• Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study.

  1992cited by this paper
• Extracorporeal photochemotherapy for cutaneous T-cell lymphoma and other diseases.

  1992cited by this paper
• Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

  1992cited by this paper
• Extracorporeal photochemotherapy.

  1992cited by this paper

• Extracorporeal Photopheresis and Heart Transplantation; A Comprehensive Review of Current Evidence

  2025cites this paper
• European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1

  2020cites this paper
• Extracorporeal photopheresis in solid organ transplantation

  2020cites this paper
• A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer.

  2020cites this paper
• Extracorporeal photopheresis: Review of technical aspects

  2017cites this paper
• La photophérèse extracorporelle (PCE) comme traitement de la maladie du greffon contre l’hôte (GVHD) aiguë et chronique : étude de performances biologiques in vitro de la PCE en système dissocié

  2017cites this paper
• Immune Modulation in Children. A South African Perspective

  2016cites this paper
• Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.

  2015cites this paper
• Current Clinical Applications of Extracorporeal Photochemotherapy

  2015influential citation
• Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards

  2014cites this paper
• Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process

  2013cites this paper
• Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome

  2013cites this paper
• Guidelines on the use of extracorporeal photopheresis

  2013cites this paper
• Treatment of ankylosing spondylitis by extracorporeal photochemotherapy given for mycosis fungoides: a potential treatment option?

  2011influential citation
• Mononuclear cell collection in patients treated with extracorporeal photochemotherapy by using the off‐line method: A comparison between COBE Spectra AutoPbsc version 6.1 and Amicus cell separators

  2010cites this paper
• Therapeutic Apheresis – Many Ways to Go

  2008cites this paper